Previously, we showed that dioscin is a potential neuroprotector in an MPP+-induced Parkinson’s disease model [22], where dioscin showed a substantial reduction of apoptosis and upregulated neurotrophic factors such as BDNF and pCREB. This evidence concerns the gene BDNF and Parkinson disease.